iShares Biotechnology ETF (IBB) — ()

Key Metrics

 

News

IBB: Now Is The Time To Be Contrarian

Published: by:
Sentiment: Positive ()

Biotech stocks have underperformed due to sector rotation, rising rates, and regulatory pressures, but I see a contrarian opportunity emerging. A close look at the recent performance of biotech stocks, …

Read More
image for news IBB: Now Is The Time To Be Contrarian
Key Stock Market ETFs, Bitcoin Creating A Story

Published: by:
Sentiment: Neutral ()

This past week I wrote a lot about the relationship between silver, gold, bonds, the dollar and S&P 500. I also spoke in the media about those relationships as they …

Read More
image for news Key Stock Market ETFs, Bitcoin Creating A Story
Trump Says Pharmaceutical Tariffs Coming in Near Future

Published: by:
Sentiment: Negative ()

President Donald Trump said tariffs on pharmaceuticals will be coming in the “not too distant future” and fit in the category of tariffs imposed on cars, steel, and aluminum. Trump …

Read More
image for news Trump Says Pharmaceutical Tariffs Coming in Near Future
Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages

Published: by:
Sentiment: Negative ()

President Donald Trump's planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences on the drug supply chain, manufacturers and American patients, some experts told CNBC. The tariffs …

Read More
image for news Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages
Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'

Published: by:
Sentiment: Negative ()

Trump doubled down on plans to soon impose "major" pharmaceutical tariffs, while early stage startups dominated digital health funding deals in first quarter.

Read More
image for news Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'

About iShares Biotechnology ETF IBB

The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.